24/7 Wall St.40d agoneutral
Prediction: Eli Lilly’s Next Growth Wave Could Surprise InvestorsNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
104last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Insider Monkey41d agoneutral
Can Roche’s Latest Obesity Drug Results Help it Challenge Eli Lilly and Novo Nordisk?Stocktwits41d agoneutral
Lilly CEO Reportedly Eyes Bigger ‘White Space’ Deals After A Record 2026 Shopping SpreeInsider Monkey41d agobullish
Novo Nordisk Just Beat Lilly in a Trial. Is the Comeback Finally Taking Shape?24/7 Wall St.41d agoneutral
Eli Lilly Wavered Over the Last Month: One of Wall Street’s Biggest Banks Says 35% Gains Still to ComeInsider Monkey42d agoneutral
Eli Lilly and Company (LLY) is Expanding Beyond its Biggest Growth Drivers. Can it Sustain the Momentum?Insider Monkey42d agoneutral
Can Novo Nordisk (NVO) Find a Second Act Before its First One Fades?Insider Monkey42d agoneutral
Gilead vs. Medtronic: Which Healthcare Stock Offers the Better Mix of Growth and Income?Insider Monkey42d agoneutral
A New Wave of Senior Patients Could Extend Lilly’s GLP-1 Growth StoryInsider Monkey42d agoneutral
Lilly’s Oral GLP-1 Push Gains Momentum. Can Foundayo Become its Next Growth Engine?24/7 Wall St.42d agoneutral
Eli Lilly Just Won FDA Approval for a Once Weekly Insulin and the Stock Is Knocking on $1,200Insider Monkey43d agoneutral
Foundayo’s Early Growth Is Raising Lilly (LLY)’s Revenue Expectations. But Can It Outrun Pricing Pressure?